Markets
News
Analysis
Tools
Learn
Features
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Markets
/
Stocks
/
nasdaq-tdacu
/
Translational Development Acquisition Corp
TDACU
10.410
USD
-0.020
-0.19%
Market hours (ET)
Quotes delayed by 15 min
USD
0.000
Pre-market (ET)
--
Market Cap
--
P/E TTM
Translational Development Acquisition Corp
10.410
-0.020
-0.19%
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Overview
Company
Financials
Statements
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024Q3
FY2023Q4
FY2023Q3
Operating expenses
12156.60%
61.28K
--
483.85K
--
500.00
Operating profit
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Net non-operating interest income (expenses)
Income before tax
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Income after tax
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Net income from continuous operations
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Net income attributable to controlling interests
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Net income attributable to common shareholders
-12156.60%
-61.28K
--
-483.85K
--
-500.00
Basic earnings per share
-10633.33%
0.00
--
-0.03
--
0.00
Diluted earnings per share
-10633.33%
0.00
--
-0.03
--
0.00
Dividend per share
--
0.00
--
0.00
--
0.00
Currency unit
USD
USD
USD
Audit opinions
--
--
--
KeyAI
Please log in to use KeyAI
Log in
Sign Up